Daehan New Pharm Co. Ltd (054670) - Total Liabilities

Latest as of September 2025: ₩122.10 Billion KRW ≈ $82.74 Million USD

Based on the latest financial reports, Daehan New Pharm Co. Ltd (054670) has total liabilities worth ₩122.10 Billion KRW (≈ $82.74 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 054670 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Daehan New Pharm Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Daehan New Pharm Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Daehan New Pharm Co. Ltd asset portfolio.

Daehan New Pharm Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Daehan New Pharm Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Harmoney Corp Ltd AU:HMY	Australia	AU$908.11 Million
Bridgford Foods Corporation NASDAQ:BRID	USA	$33.26 Million
Nimbus Group AB ST:BOAT	Sweden	Skr756.82 Million
Microtips Technology TWO:3285	Taiwan	NT$697.96 Million
Top Win International Limited NASDAQ:SORA	USA	$2.30 Million
Zimmite Taiwan Ltd TWO:8435	Taiwan	NT$140.55 Million
Greenland Energy Company Common Stock NASDAQ:GLND	USA	$1.36 Million
Generic Sweden publ AB ST:GENI	Sweden	Skr38.55 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Daehan New Pharm Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Daehan New Pharm Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.94	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.49	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daehan New Pharm Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daehan New Pharm Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Daehan New Pharm Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩95.85 Billion ≈ $64.95 Million	+41.84%
2023-12-31	₩67.57 Billion ≈ $45.79 Million	+1.76%
2022-12-31	₩66.40 Billion ≈ $45.00 Million	-11.68%
2021-12-31	₩75.18 Billion ≈ $50.95 Million	-1.01%
2020-12-31	₩75.95 Billion ≈ $51.47 Million	+13.62%
2019-12-31	₩66.84 Billion ≈ $45.30 Million	+1.80%
2018-12-31	₩65.66 Billion ≈ $44.49 Million	-6.33%
2017-12-31	₩70.09 Billion ≈ $47.50 Million	+17.77%
2016-12-31	₩59.52 Billion ≈ $40.33 Million	+7.38%
2015-12-31	₩55.43 Billion ≈ $37.56 Million	-2.03%
2014-12-31	₩56.58 Billion ≈ $38.34 Million	--

About Daehan New Pharm Co. Ltd

KQ:054670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$52.98 Million

₩78.18 Billion KRW

Market Cap Rank

#21781 Global

#1307 in Korea

Share Price

₩5570.00

Change (1 day)

+0.00%

52-Week Range

₩5090.00 - ₩7510.00

All Time High

₩21012.38